Lista de obras - Anna L. Fracanzani - Dominio Público Uruguay

A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis

artículo científico publicado en 2010

A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia.

scientific article published on March 2014

A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype.

artículo científico publicado en 2010

Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.

artículo científico publicado en 2005

Association between iron overload and osteoporosis in patients with hereditary hemochromatosis

artículo científico publicado en 2008

Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda

artículo científico publicado en 2001

Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2010

Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations: response to Equitani et al.

artículo científico publicado en 2008

Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload

artículo científico publicado el 1 de septiembre de 1997

Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review

artículo científico publicado en 2019

CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients

artículo científico publicado en 2012

Can nonalcoholic steatohepatitis trigger porphyria cutanea tarda clinical manifestations?

article

Carotid artery intima-media thickness in nonalcoholic fatty liver disease

artículo científico publicado en 2008

Combined use of genetic polymorphisms and elastographic techniques in NAFLD. Fact or fiction?

scientific article published on 21 November 2019

Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis

artículo científico publicado en 2001

Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients

artículo científico publicado en 2004

Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis.

artículo científico publicado en 2012

Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.

artículo científico publicado en 2016

Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease

scientific article published on 11 January 2019

Ferroportin-1 in the recurrence of hepatic iron overload after liver transplantation

artículo científico publicado en 2008

Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.

artículo científico publicado en 2012

Genetic hemochromatosis in Italian patients with prophyria cutanea tarda: possible explanation for iron overload

article

Genetic variants in the MTHFR are not associated with fatty liver disease

artículo científico publicado en 2020

Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.

artículo científico publicado en 2010

HFE Gene Mutations and Oxidative Stress Influence Serum Ferritin, Associated with Vascular Damage, in Hemodialysis Patients

article

HFE Genotype Influences Erythropoiesis Support Requirement in Hemodialysis Patients: A Prospective Study

scientific article published on 16 November 2007

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2009

HFEmutations in nonalcoholic fatty liver disease

scientific article published on 01 May 2008

Harmful and Beneficial Effects of Anti-coagulants in Patients With Cirrhosis and Portal Vein Thrombosis

artículo científico publicado en 2017

Hemochromatosis gene (HFE) mutations and cancer risk: Expanding the clinical manifestations of hereditary iron overload

article

Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors

artículo científico publicado en 2010

Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.

artículo científico publicado en 2014

High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload

artículo científico publicado en 2015

High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda

artículo científico publicado el 1 de diciembre de 1997

High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda

artículo científico publicado en 1998

Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development.

artículo científico publicado en 2003

Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis

artículo científico publicado en 2008

Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.

artículo científico publicado en 2001

Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis

artículo científico publicado en 2003

Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

artículo científico publicado en 2007

Iron genes, dysmetabolism and fibrosis in chronic hepatitis C

article

Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target ⬇️

artículo científico publicado el 28 de junio de 2011

Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study

artículo científico publicado en 2010

Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.

artículo científico publicado en 2017

Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease

artículo científico publicado en 2001

Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection

artículo científico publicado en 1992

Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes

scientific article published on 31 October 2019

Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis

artículo científico publicado en 2012

Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy

artículo científico publicado en 2013

Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma

artículo científico publicado en 2001

No association between genetic hemochromatosis and alpha1-antitrypsin deficiency

artículo científico publicado en 1996

Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

artículo científico publicado en 2014

PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD

artículo científico publicado en 2020

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2013

PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma

artículo científico publicado en 2013

Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

artículo científico publicado en 2011

Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.

artículo científico publicado en 2012

Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis

scientific article published on 29 January 2019

Prevalence of hepatitis C virus infection in porphyria cutanea tarda

artículo científico publicado en 2003

Procoagulant imbalance in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2014

Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis

scientific article published on 30 August 2019

Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis

artículo científico publicado en 1994

Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.

artículo científico publicado en 2016

Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis

artículo científico publicado en 2007

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

artículo científico publicado en 2010

Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease

artículo científico publicado en 2014

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

artículo científico publicado en 2008

Role of iron in hepatocellular carcinoma

artículo científico publicado en 2014

Saturability of hepatic iron deposits in genetic hemochromatosis

artículo científico publicado en 1992

Searching for coeliac disease in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2004

Serum Hepcidin and Macrophage Iron Correlate With MCP-1 Release and Vascular Damage in Patients With Metabolic Syndrome Alterations

artículo científico publicado en 2010

Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity

scientific article published on 26 June 2019

Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.

artículo científico publicado en 2010

Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study

artículo científico publicado en 2017

Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease

artículo científico publicado en 2012

Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon

artículo científico publicado en 2003

TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.

artículo científico publicado en 2005

TNFalpha promoter polymorphisms in Italian patients with porphyria cutanea tarda.

artículo científico publicado en 2003

The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease

artículo científico publicado en 2012

The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver

artículo científico publicado en 2011

The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls

artículo científico publicado en 2012

The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies

scientific article published on 12 July 2011

The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.

artículo científico publicado en 2014

The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis.

artículo científico publicado en 2004

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

artículo científico publicado en 2015

Treatment choices for people infected with HCV.

artículo científico publicado en 2004

Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis

artículo científico publicado en 2001

Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study

artículo científico publicado en 2010

What is the contribution of differences in three measures of tumor necrosis factor-alpha activity to insulin resistance in healthy volunteers?

artículo científico publicado en 2003

Lista de obras de Anna L. Fracanzani

A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis

A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia.

A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype.

Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.

Association between iron overload and osteoporosis in patients with hereditary hemochromatosis

Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda

Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease

Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations: response to Equitani et al.

Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload

Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review

CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients

Can nonalcoholic steatohepatitis trigger porphyria cutanea tarda clinical manifestations?

Carotid artery intima-media thickness in nonalcoholic fatty liver disease

Combined use of genetic polymorphisms and elastographic techniques in NAFLD. Fact or fiction?

Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis

Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients

Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis.

Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.

Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease

Ferroportin-1 in the recurrence of hepatic iron overload after liver transplantation

Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.

Genetic hemochromatosis in Italian patients with prophyria cutanea tarda: possible explanation for iron overload

Genetic variants in the MTHFR are not associated with fatty liver disease

Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.

HFE Gene Mutations and Oxidative Stress Influence Serum Ferritin, Associated with Vascular Damage, in Hemodialysis Patients

HFE Genotype Influences Erythropoiesis Support Requirement in Hemodialysis Patients: A Prospective Study

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease

HFEmutations in nonalcoholic fatty liver disease

Harmful and Beneficial Effects of Anti-coagulants in Patients With Cirrhosis and Portal Vein Thrombosis

Hemochromatosis gene (HFE) mutations and cancer risk: Expanding the clinical manifestations of hereditary iron overload

Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors

Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.

High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload

High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda

High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda

Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development.

Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis

Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.

Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis

Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

Iron genes, dysmetabolism and fibrosis in chronic hepatitis C

Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target ⬇️

Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study

Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.

Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease

Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection

Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes

Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis

Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy

Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma

No association between genetic hemochromatosis and alpha1-antitrypsin deficiency

Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease

PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma

Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.

Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis

Prevalence of hepatitis C virus infection in porphyria cutanea tarda

Procoagulant imbalance in patients with non-alcoholic fatty liver disease

Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis

Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis

Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.

Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

Role of iron in hepatocellular carcinoma

Saturability of hepatic iron deposits in genetic hemochromatosis

Searching for coeliac disease in patients with non-alcoholic fatty liver disease

Serum Hepcidin and Macrophage Iron Correlate With MCP-1 Release and Vascular Damage in Patients With Metabolic Syndrome Alterations

Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity

Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.

Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study

Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease

Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon

TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.

TNFalpha promoter polymorphisms in Italian patients with porphyria cutanea tarda.

The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease